Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Abstract
Abstract Quantification of variation in levels of spontaneously occurring cancer driver mutations (CDMs) was developed to assess clonal expansion and predict future risk of neoplasm development. Specifically, an error-corrected next-generation sequencing method, CarcSeq, and a mouse CarcSeq panel (analogous to human and rat panels) were developed and used to quantify low-frequency mutations in a panel of amplicons enriched in hotspot CDMs. Mutations in a subset of panel amplicons, Braf, Egfr, Kras, Stk11, and Tp53, were related to incidence of lung neoplasms at 2 years. This was achieved by correlating median absolute deviation (MAD) from the overall median mutant fraction (MF) measured in the lung DNA of 16-week-old male and female, B6C3F1 and CD-1 mice (10 mice/sex/strain) with percentages of spontaneous alveolar/bronchioloalveolar adenomas and carcinomas reported in bioassay control groups. A total of 1586 mouse lung mutants with MFs >1 × 10−4 were recovered. The ratio of nonsynonymous to synonymous mutations was used to assess the proportion of recovered mutations conferring a positive selective advantage. The greatest ratio was observed in what is considered the most lung tumor-sensitive model examined, male B6C3F1 mice. Of the recurrent, nonsynonymous mouse mutations recovered, 55.5% have been reported in human tumors, with many located inmore »
- Authors:
-
- Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, USA
- Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, USA
- Publication Date:
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1814548
- Resource Type:
- Publisher's Accepted Manuscript
- Journal Name:
- Toxicological Sciences
- Additional Journal Information:
- Journal Name: Toxicological Sciences; Journal ID: ISSN 1096-6080
- Publisher:
- Oxford University Press
- Country of Publication:
- United States
- Language:
- English
Citation Formats
Harris, Kelly L., McKim, Karen L., Myers, Meagan B., Gong, Binsheng, Xu, Joshua, and Parsons, Barbara L. Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia. United States: N. p., 2021.
Web. doi:10.1093/toxsci/kfab098.
Harris, Kelly L., McKim, Karen L., Myers, Meagan B., Gong, Binsheng, Xu, Joshua, & Parsons, Barbara L. Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia. United States. https://doi.org/10.1093/toxsci/kfab098
Harris, Kelly L., McKim, Karen L., Myers, Meagan B., Gong, Binsheng, Xu, Joshua, and Parsons, Barbara L. Mon .
"Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia". United States. https://doi.org/10.1093/toxsci/kfab098.
@article{osti_1814548,
title = {Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia},
author = {Harris, Kelly L. and McKim, Karen L. and Myers, Meagan B. and Gong, Binsheng and Xu, Joshua and Parsons, Barbara L.},
abstractNote = {Abstract Quantification of variation in levels of spontaneously occurring cancer driver mutations (CDMs) was developed to assess clonal expansion and predict future risk of neoplasm development. Specifically, an error-corrected next-generation sequencing method, CarcSeq, and a mouse CarcSeq panel (analogous to human and rat panels) were developed and used to quantify low-frequency mutations in a panel of amplicons enriched in hotspot CDMs. Mutations in a subset of panel amplicons, Braf, Egfr, Kras, Stk11, and Tp53, were related to incidence of lung neoplasms at 2 years. This was achieved by correlating median absolute deviation (MAD) from the overall median mutant fraction (MF) measured in the lung DNA of 16-week-old male and female, B6C3F1 and CD-1 mice (10 mice/sex/strain) with percentages of spontaneous alveolar/bronchioloalveolar adenomas and carcinomas reported in bioassay control groups. A total of 1586 mouse lung mutants with MFs >1 × 10−4 were recovered. The ratio of nonsynonymous to synonymous mutations was used to assess the proportion of recovered mutations conferring a positive selective advantage. The greatest ratio was observed in what is considered the most lung tumor-sensitive model examined, male B6C3F1 mice. Of the recurrent, nonsynonymous mouse mutations recovered, 55.5% have been reported in human tumors, with many located in or around the mouse equivalent of human cancer hotspot codons. MAD for the same subset of amplicons measured in normal human lung DNA samples showed a correlation of moderate strength and borderline significance with age (a cancer risk factor), as well as age-related cumulative lung cancer risk, suggesting MAD may inform species extrapolation.},
doi = {10.1093/toxsci/kfab098},
journal = {Toxicological Sciences},
number = ,
volume = ,
place = {United States},
year = {Mon Aug 09 00:00:00 EDT 2021},
month = {Mon Aug 09 00:00:00 EDT 2021}
}
https://doi.org/10.1093/toxsci/kfab098
Works referenced in this record:
Quantification of cancer driver mutations in human breast and lung DNA using targeted, error‐corrected CarcSeq
journal, September 2020
- Harris, Kelly L.; Walia, Vijay; Gong, Binsheng
- Environmental and Molecular Mutagenesis, Vol. 61, Issue 9
The mutational landscape of normal human endometrial epithelium
journal, April 2020
- Moore, Luiza; Leongamornlert, Daniel; Coorens, Tim H. H.
- Nature, Vol. 580, Issue 7805
Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas
journal, April 2016
- Myers, Meagan B.; Banda, Malathi; McKim, Karen L.
- Neoplasia, Vol. 18, Issue 4
Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium
journal, August 2018
- Suda, Kazuaki; Nakaoka, Hirofumi; Yoshihara, Kosuke
- Cell Reports, Vol. 24, Issue 7
Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment
journal, October 2001
- McKinzie, P.
- Mutation Research/Reviews in Mutation Research, Vol. 489, Issue 1
Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan
journal, July 2019
- Salk, Jesse J.; Loubet-Senear, Kaitlyn; Maritschnegg, Elisabeth
- Cell Reports, Vol. 28, Issue 1
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis
journal, June 2016
- Smith, Martyn T.; Guyton, Kathryn Z.; Gibbons, Catherine F.
- Environmental Health Perspectives, Vol. 124, Issue 6
Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk
journal, October 2019
- Harris, Kelly L.; Myers, Meagan B.; McKim, Karen L.
- Environmental and Molecular Mutagenesis, Vol. 61, Issue 1
Age-related remodelling of oesophageal epithelia by mutated cancer drivers
journal, January 2019
- Yokoyama, Akira; Kakiuchi, Nobuyuki; Yoshizato, Tetsuichi
- Nature, Vol. 565, Issue 7739
High burden and pervasive positive selection of somatic mutations in normal human skin
journal, May 2015
- Martincorena, I.; Roshan, A.; Gerstung, M.
- Science, Vol. 348, Issue 6237
CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia
journal, April 2021
- McKim, Karen L.; Myers, Meagan B.; Harris, Kelly L.
- Toxicological Sciences, Vol. 182, Issue 1
The Tg rasH2 Mouse in Cancer Hazard Identification
journal, January 2002
- Morton, Daniel; Alden, Carl L.; Roth, Arthur J.
- Toxicologic Pathology, Vol. 30, Issue 1
Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas: Tissue-Specific Properties of Hotspot Cancer-Driver Mutations
journal, July 2017
- Parsons, Barbara L.; McKim, Karen L.; Myers, Meagan B.
- Environmental and Molecular Mutagenesis, Vol. 58, Issue 7
Changing the field of carcinogenicity testing of human pharmaceuticals by emphasizing mode of action
journal, April 2017
- van der Laan, Jan Willem; Duijndam, Britt; van den Hoorn, Tineke
- Current Opinion in Toxicology, Vol. 3
Carcinogenicity Evaluation: Comparison of Tumor Data from Dual Control Groups in the CD–1 Mouse
journal, June 2007
- Baldrick, Paul; Reeve, Lesley
- Toxicologic Pathology, Vol. 35, Issue 4
A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies
journal, February 2020
- Yauk, Carole L.; Harrill, Alison H.; Ellinger-Ziegelbauer, Heidrun
- Regulatory Toxicology and Pharmacology, Vol. 110
Somatic mutant clones colonize the human esophagus with age
journal, October 2018
- Martincorena, Iñigo; Fowler, Joanna C.; Wabik, Agnieszka
- Science, Vol. 362, Issue 6417
Universal Patterns of Selection in Cancer and Somatic Tissues
journal, November 2017
- Martincorena, Iñigo; Raine, Keiran M.; Gerstung, Moritz
- Cell, Vol. 171, Issue 5
Incidence of Spontaneous Non-Neoplastic Lesions in Transgenic CBYB6F1-Tg(HRAS)2Jic Mice
journal, February 2013
- Paranjpe, Madhav G.; Shah, Sudhir A.; Denton, Melissa D.
- Toxicologic Pathology, Vol. 41, Issue 8
A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroid: KRAS MUTANT FRACTION IN PAPILLARY THYROID TUMORS
journal, August 2012
- Myers, Meagan B.; McKim, Karen L.; Parsons, Barbara L.
- Molecular Carcinogenesis, Vol. 53, Issue 2
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
journal, August 2016
- Young, Andrew L.; Challen, Grant A.; Birmann, Brenda M.
- Nature Communications, Vol. 7, Issue 1
Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision Oncology
journal, February 2019
- Myers, Meagan; McKim, Karen; Banda, Malathi
- International Journal of Molecular Sciences, Vol. 20, Issue 5
Gender differences in the incidence of background and chemically induced primary pulmonary neoplasms in B6C3F1 mice: A retrospective analysis of the National Toxicology Program (NTP) carcinogenicity bioassays
journal, November 2013
- Moore, Nigel P.; McFadden, Lisa G.; Landenberger, Bryce D.
- Experimental and Toxicologic Pathology, Vol. 65, Issue 7-8
Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop
journal, December 2017
- Corvi, Raffaella; Madia, Federica; Guyton, Kathryn Z.
- Toxicology in Vitro, Vol. 45
Selective Pressures on Human Cancer Genes along the Evolution of Mammals
journal, November 2018
- Vicens, Alberto; Posada, David
- Genes, Vol. 9, Issue 12
ACB-PCR Quantification of K- RAS Codon 12 GAT and GTT Mutant Fraction in Colon Tumor and Non-Tumor Tissue
journal, April 2010
- Parsons, Barbara L.; Marchant-Miros, Kathryn E.; Delongchamp, Robert R.
- Cancer Investigation, Vol. 28, Issue 4
Age and Cancer Risk
journal, March 2014
- White, Mary C.; Holman, Dawn M.; Boehm, Jennifer E.
- American Journal of Preventive Medicine, Vol. 46, Issue 3
Relevance of mouse lung tumors to human risk assessment
journal, May 2020
- Cohen, Samuel M.; Zhongyu, Yan; Bus, James S.
- Journal of Toxicology and Environmental Health, Part B, Vol. 23, Issue 5
Multiclonal tumor origin: Evidence and implications
journal, July 2018
- Parsons, Barbara L.
- Mutation Research/Reviews in Mutation Research, Vol. 777
Next‐Generation Genotoxicology: Using Modern Sequencing Technologies to Assess Somatic Mutagenesis and Cancer Risk
journal, November 2019
- Salk, Jesse J.; Kennedy, Scott R.
- Environmental and Molecular Mutagenesis, Vol. 61, Issue 1
Differential Transcriptomic Analysis of Spontaneous Lung Tumors in B6C3F1 Mice: Comparison to Human Non–Small Cell Lung Cancer
journal, June 2012
- Pandiri, Arun R.; Sills, Robert C.; Ziglioli, Vincent
- Toxicologic Pathology, Vol. 40, Issue 8
Low-frequency KRAS mutations are prevalent in lung adenocarcinomas
journal, March 2015
- Myers, Meagan B.; McKim, Karen L.; Meng, Fanxue
- Personalized Medicine, Vol. 12, Issue 2
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
journal, October 2018
- Sondka, Zbyslaw; Bamford, Sally; Cole, Charlotte G.
- Nature Reviews Cancer, Vol. 18, Issue 11